NetworkNewsBreaks – Grey Cloak Tech Inc. (GRCK) Announces Positive Clinical Study Results for ‘HERHEART(TM)’
Grey Cloak Tech (OTCQB: GRCK) (soon to be Healthy Extracts Inc.), a company engaged in proprietary development of natural plant-based formulations and sales and distribution of clinically proven cardiovascular and neuro products, today announced that the newly released clinical study of BergaMet NA’s HERHEART(TM) product produced incredible results. In addition, the company announced the appointment of internationally renowned Dr. Nesochi Okeke-Igokwe MD., M.S to its medical advisory board to promote women’s health. “Cardiovascular disease is the number one cause of death for women in the United States,” said Duke Pitts, CEO of BergaMet NA. “HERHEART was specifically formulated to fill…